UBS O'Connor’s St Jude Medical STJ Stock Holding History

UBS O'Connor’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,157,846	Closed	-$173M	–	530
2016 Q4	$173M	Buy	2,157,846 +674,652	+45%	+$53.5M	3.34%	2
2016 Q3	$118M	Buy	1,483,194 +207,569	+16%	+$16.8M	1.76%	7
2016 Q2	$99.5M	Buy	+1,275,625	New	+$91M	2.15%	5
2015 Q2	–	Sell	-4,306	Closed	-$282K	–	984
2015 Q1	$282K	Hold	4,306	–	–	0.01%	626
2014 Q4	$280K	Buy	+4,306	New	+$277K	﹤0.01%	555

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

UBS O'Connor's STJ Position: Q1 2017 in Review

UBS O'Connor sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,157,846 shares — an estimated $173M sold.

UBS O'Connor first reported a position in STJ in Q4 2014 and held it in 5 quarters. The position peaked at $173M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

UBS O'Connor reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
UBS O'Connor sold 2,157,846 St Jude Medical shares in Q1 2017, an estimated $173M.
UBS O'Connor first reported a position in St Jude Medical in Q4 2014 and held it in 5 quarters.
UBS O'Connor's St Jude Medical position peaked at $173M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on UBS O'Connor's 13F filing for Q1 2017, filed 12 May 2017.